KLKe Lu

Ke Lu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ke Lu has a total of 174 co-authors. Here are the top co-authors by number of shared publications:

  • Chong Li

    Affiliations Kunshan Biomedical Big Data Innovation Application Laboratory, Suzhou, Jiangsu, China, Department of Orthopedics, Traditional Chinese Medicine Hospital of Kunshan, Suzhou, Jiangsu, China

    47 shared publications
  • Ya-Qin Gong

    Information Department, Affiliated Kunshan Hospital of Jiangsu University, Suzhou, China

    16 shared publications
  • Ya-Qin Gong

    Information Department, Affiliated Kunshan Hospital of Jiangsu University

    15 shared publications
  • Chong Li

    Department of Orthopedics, Affiliated Kunshan Hospital of Jiangsu University

    13 shared publications
  • Min-Zhe Xu

    Department of Orthopedics, Affiliated Kunshan Hospital of Jiangsu University, Suzhou, China

    11 shared publications
  • Qin Shi

    Department of Orthopedics, The First Affiliated Hospital of Soochow University, Orthopedic Institute of Soochow University, Medical College of Soochow University, 899 Pinghai Road, Suzhou, Jiangsu, 215031, PR China

    11 shared publications

Latest Publications

  • Open Access

    Non-HDL-C/HDL-C ratio and prevalent hyperuricemia in adults hospitalized with fractures: a retrospective cross-sectional study

    by Ming-Xin Chen, Li-Long Feng, Xiang-Yu Huang, Cheng Wang, Ke Lu, Hui-Qiang Shan

    Background: We assessed the association between the non-high-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio (NHHR) and prevalent hyperuricemia (HUA) in adults hospitalized with fractures. We also examined overlap with other lipid measures and exploratory incremental discrimination. Methods: This retrospective cross-sectional study included 2699 adults aged ≥ 50 years with observed serum uric acid, total cholesterol, and high-density lipoprotein cholesterol (HDL-C). Each patient contributed one index hospitalization, defined as the first eligible hospitalization during the study period. Fasting biochemical measurements were obtained within the first 24 hours after admission; later inpatient values were excluded. HUA was defined as serum uric acid ≥ 416 μmol/L in men or ≥357 μmol/L in women. We estimated prevalence odds ratios (ORs) and modified-Poisson prevalence ratios (PRs) as complementary measures of association across 20 multiple-imputation (MI) datasets. Models used clinically informed covariates and flexible estimated glomerular filtration rate (eGFR) adjustment. Complete-case, selection-weighted, and alternative-threshold analyses assessed sensitivity. Results: HUA was present in 418 patients (15.5%). Per one standard deviation (SD) higher NHHR, the MI-pooled OR was 1.188 (95% confidence interval [CI] 1.061–1.330; p = 0.003). The corresponding PR was 1.129 (95% CI 1.045–1.220; p = 0.002). Selection-weighted estimates were similar (OR 1.191; PR 1.131), although lipid missingness and limited positivity constrain interpretation. The complete-case OR was 1.130 (95% CI 0.999–1.277). Nonlinear evidence was unstable after trimming extreme NHHR values. In a joint model including triglycerides and low-density lipoprotein cholesterol, the NHHR OR was 1.046 (95% CI 0.876–1.248). Adding NHHR changed cross-validated area under the receiver operating characteristic curve (AUC) from 0.777 to 0.780 (ΔAUC 0.0026; conditional 95% interval −0.0016–0.0070). Conclusions: NHHR showed a modest association with prevalent HUA in this selected fracture-hospitalized population. Interpretation is tempered by missing-data assumptions, overlapping lipid information, and limited incremental discrimination. Fasting first-24-hour sampling cannot fully distinguish chronic metabolic status from acute hospitalization physiology; no validated prediction role or clinical NHHR cutoff is established. Clinical trial number: Not applicable.

  • Open Access

    Previous schistosome infection and the risk of incident hyperuricemia: A prospective cohort study

    by Congyue Wang, Zijian Tian, Ying Yang, Yushan Yue, Kaixin Zhou, Chong Li, Ke Lu

    Introduction: Although prior research in China has linked previous schistosome infection (PSI) to lower risks of metabolic syndrome and cardiorenovascular conditions, the association between PSI and hyperuricemia, a recognized risk factor for these conditions, remains unclear. This study examines the relationship between PSI and hyperuricemia and identifies factors associated with hyperuricemia incidence in individuals with PSI. Methods: This prospective cohort study included 23,051 adults from eight health centers in Kunshan (2018–2021). Exposure was defined by self-reported PSI, validated by liver B-ultrasound. The primary outcome was hyperuricemia. Baseline and follow-up data encompassed height, weight, blood pressure, serum uric acid, glucose, renal function parameters, liver function, and lipid profiles. Cox proportional hazard models were employed to analyze the relationship between PSI and hyperuricemia, adjusting for demographic, lifestyle, and clinical variables. Results: Among the 23,051 participants included in this study, 4,677 (20.29%) had a history of schistosome infection, and 87.53% of those with PSI were over the age of 64. During 60,335 person-years of follow-up, 4,417 incident cases of hyperuricemia were recorded. The incidence rate was 64.91 per 1,000 person-years in the PSI group and 75.38 per 1,000 person-years in the non-PSI group. The overall cumulative hazard differed significantly among individuals, with the incidence of hyperuricemia being 17.36% (95% CI: 16.28–18.48%) and 19.62% (95% CI: 19.05–20.20%) in PSI and Non-PSI groups. After adjusting for confounders, PSI was associated with an 11% lower risk of hyperuricemia (HR: 0.89, 95% CI: 0.82–0.97, p = 0.005). Conclusions: In this prospective cohort study, PSI was observed to be associated with a lower risk of incident hyperuricemia. This finding reflects an observational association and does not establish causality. From a public health standpoint, schistosome infection remains a serious disease requiring continued prevention and control. Further investigations are needed to clarify the underlying mechanisms linking PSI to hyperuricemia.

  • Open Access

    Comparative Risk of First Hospitalized Vertebral Fracture with Denosumab Versus Zoledronic Acid: A Real-World Cohort Study

    by Wen Cheng, Guo-Ji Lin, Jia-Qi Liang, Ya-Qin Gong, Jia-Chen Zhu, Jian Jin, Jian Zhang, Yu-Shan Yue, Chong Li, Ke Lu

    This retrospective new-user cohort study evaluated the association between denosumab 60 mg and zoledronic acid 5 mg with first hospitalized vertebral fracture in adults aged ≥50 years receiving routine care in a Chinese hospital system. Eligible treatment initiators were identified from hospital injection and administration records at the Affiliated Kunshan Hospital of Jiangsu University between October 2021 and December 2024. Patients with a history of vertebral fracture, cancer, Paget disease, or previous alendronate use were excluded. The primary outcome was the first hospitalized vertebral fracture occurring >30 days after treatment initiation. The complete-case cohort consisted of 3,116 treatment initiators, with a total of 60 events, including 27 among patients receiving zoledronic acid and 33 among those receiving denosumab. In crude analysis, denosumab was associated with a higher fracture hazard than zoledronic acid (HR 3.02, 95% CI 1.46–6.26). In the primary overlap-weighted analysis, which estimated the average treatment effect in the overlap population, the HR was 2.05 (95% CI, 0.88–4.78). The doubly robust overlap-weighted analysis yielded an HR of 1.64 (95% CI, 0.65–4.17). All adjusted confidence intervals included the null; therefore, the adjusted analyses did not demonstrate a statistically significant difference between treatments. These findings should be interpreted with caution because of the limited number of events, treatment channeling, calendar imbalance, incomplete information on treatment persistence, and the potential for residual confounding.

  • Open Access

    Nonlinear relationship between circulating homocysteine and parathyroid hormone among patients with osteoporotic fractures: A cross-sectional study based on a hospital cohort

    by Jia-Hao Wang, Wei-Hong Wang, Da-Wei He, Ke Lu, Chong Li, Yan-Ming Hao

    Osteoporotic fractures are frequent among older adults and are often accompanied by disturbances in endocrine and metabolic regulation. Parathyroid hormone (PTH) serves as a key regulator of bone remodeling, while elevated plasma homocysteine—an established marker of vascular injury and skeletal fragility—has been implicated in osteoporosis. Yet, the interaction between these two biochemical factors remains insufficiently characterized. This study investigated the link between circulating homocysteine and serum PTH concentrations among 2,190 hospitalized patients with osteoporotic fractures, emphasizing nonlinear associations and modifying influences. Fasting blood samples obtained at admission were used to measure plasma homocysteine and intact PTH levels. Multiple regression and spline-based modeling techniques were employed to estimate independent relationships and potential threshold effects, with subgroup analyses considering hypertension, renal function, and magnesium status. Homocysteine demonstrated an independent, positive correlation with PTH (P < 0.001). A nonlinear dose–response relationship was observed, wherein PTH increased progressively with homocysteine up to about 18 μmol/L, followed by a sharper rise beyond this point, suggesting a statistically significant threshold. The relationship was more evident among patients with hypertension, impaired renal function, or low magnesium levels, indicating that vascular strain, renal stress, and mineral imbalance may heighten PTH activity. Elevated homocysteine levels may be associated with higher PTH concentrations in individuals with osteoporosis. However, the clinical relevance of homocysteine in metabolic assessment and risk stratification requires further validation.

  • Open Access

    Relationship between short-term exposure to ambient sulfur dioxide and length of hospital stay after surgery for osteoporotic fractures: a distributed lag non-linear analysis

    by Yong-Xu Liu, Jia-Qi Liang, Guo-Ji Lin, Hong-Yi Jiang, Min-Jun Zhang, Lin Chen, Shan‑Jun Yan, Ting Wang, Xi Qian, Ya-Qin Gong, et al.

    While long-term air pollution is a known risk factor for fracture, its short-term impact on prognosis, particularly length of stay (LOS) in hospital following surgery, remains unclear. This study aimed to assess the relationship between short-term exposure to ambient sulfur dioxide (SO2) and LOS among patients undergoing surgery for osteoporotic fractures. A retrospective observational analysis of secondary hospital records from 3567 patients treated in Kunshan, China, between 2017 and 2024 was conducted. Individual clinical records were linked to daily area-level ambient SO₂ and meteorological data, and a distributed lag non-linear model was used to assess the association between short-term SO₂ exposure and LOS. A non-linear, J-shaped association was identified between SO2 exposure and LOS, with an apparent inflection point around 8.1 µg/m3. However, the timing of the effects, namely, the lag structure, shifted according to the degree of exposure. Moderate levels (P75) were linked to a transient, inverted U-shaped impact that reached its peak at lag 5 (percentage increase: 1.03%; 95% CI: 0.46, 1.59). By contrast, high-intensity exposure (P95) appeared to trigger a more persistent form of toxicity, with risks peaking at lag 12 (percentage increase: 2.37%; 95% CI: 1.00, 3.76). Stratified analyses suggested higher susceptibility among female patients and those admitted in winter. Short-term ambient SO₂ exposure was associated with prolonged LOS after osteoporotic fracture surgery, particularly at higher levels of exposure. These findings highlight the potential relevance of ambient air pollution to postoperative outcomes in vulnerable patient populations.

  • Open Access

    Precision Prevention of COPD with Fermented Cordyceps Preparation in High-Risk Populations: A Genotype-Dependent Real-World Study in China

    by Xiaozhou Zhou, Peng Wu, Zijian Tian, Tian Xie, Chong Li, Ke Lu, Tao Li, Yushan Yue, Jie Bai, Ziqing Liu, et al.

    Background: Chronic obstructive pulmonary disease (COPD) is an irreversible, progressive respiratory disease, and there is a lack of effective intervention strategies for high-risk populations. COPD pathogenesis is closely associated with apoptosis of lung cells. Fermented Cordyceps Preparation (FCP), a standardized traditional Chinese medicinal product, can improve lung function and exert anti-apoptotic effects by targeting caspase-3 (CASP3). However, real-world evidence regarding its preventive effect on COPD and the determinants of interindividual treatment response remains limited. Objective: We hypothesized that FCP could reduce incident COPD risk, and the genetic variation in CASP3 would regulate the preventive efficacy of FCP in a genotype-specific manner. This study aimed to validate this hypothesis and provide evidence for personalized COPD prevention. Methods: A prospective cohort study was conducted using electronic health record (EHR) and genomic data from the Kunshan Aging Research with E-health (KARE) cohort. A total of 4453 individuals were enrolled and stratified into the FCP Used Group (n=956) and FCP Unused Group (n=3497) after 1:4 propensity score matching (PSM). Kaplan-Meier survival analysis, multivariable Cox proportional hazards regression, and gene-environment interaction analysis were used to assess the association between FCP use and incident COPD, as well as the genotype-specific effect. Results: FCP use was significantly associated with a 27% reduction in incident COPD risk in the overall high-risk cohort (HR=0.73; P=0.01). Stratified analysis revealed that FCP exerted a robust preventive effect exclusively in CASP3 rs12108497 TT genotype carriers (HR=0.55; P<0.001), with no statistically significant benefit in CC or CT carriers. Notably, TT carriers in the untreated group exhibited higher baseline susceptibility to COPD (HR = 1.26; P = 0.02), and FCP intervention effectively neutralized this inherent genetic risk. A significant genotype-by-treatment interaction was observed (P for interaction = 0.02). Conclusions: This real-world study provides evidence that FCP use is associated with a reduced risk of incident COPD, with the CASP3 rs12108497 TT genotype identifying a subgroup deriving exceptional preventive benefit. These findings highlight the potential of FCP as a personalized preventive agent for COPD and provide a novel genetic stratification strategy for high-risk populations.

  • Open Access

    Clinically Interpretable Sepsis Early Warning via LLM-Guided Simulation of Temporal Physiological Dynamics

    by Weizhi Nie, Zhen Qu, Weijie Wang, Chunpei Li, Ke Lu, Bingyang Zhou, Hongzhi Yu

    Timely and interpretable early warning of sepsis remains a major clinical challenge due to the complex temporal dynamics of physiological deterioration. Traditional data-driven models often provide accurate yet opaque predictions, limiting physicians’ confidence and clinical applicability. To address this limitation, we propose a Large Language Model (LLM)-guided temporal simulation framework that explicitly models physiological trajectories prior to disease onset for clinically interpretable prediction. The framework consists of a spatiotemporal feature extraction module that captures dynamic dependencies among multivariate vital signs, a Medical Prompt-as-Prefix module that embeds clinical reasoning cues into LLMs, and an agent-based post-processing component that constrains predictions within physiologically plausible ranges. By first simulating the evolution of key physiological indicators and then classifying sepsis onset, our model offers transparent prediction mechanisms that align with clinical judgment. Evaluated on the MIMIC-IV and eICU databases, the proposed method achieves superior AUC scores (0.861–0.903) across 24–4-hour pre-onset prediction tasks, outperforming conventional deep learning and rule-based approaches. More importantly, it provides interpretable trajectories and risk trends that can assist clinicians in early intervention and personalized decision-making in intensive care environments.


  • Open Access

    A longitudinal dataset of hypertensive osteoporotic fracture patients: treatments and long-term outcomes

    by Chong Li, Ke Lu, Li-Wen Su, Peng Zhou, Guo-Ji Lin, Jia-Qi Liang, Ya-Qin Gong, Jian Jin, Wen-Rong Xu

    Osteoporotic fractures (OPF) and hypertension frequently co-occur in older adults, yet comprehensive datasets integrating clinical, pharmacological, and longitudinal outcome data remain scarce. We describe a longitudinal dataset derived from the Osteoporotic Fracture Registration System at Kunshan Hospital, Jiangsu University, including patients aged ≥ 50 years hospitalized for OPF between 2017 and 2024. A total of 4,782 patients were initially registered. After applying predefined eligibility criteria, 4,325 patients were included in the final analytical cohort. The dataset integrates demographic, clinical, and pharmacologic variables with long-term outcomes on mortality and refracture through deterministic linkage with regional health and mortality registries. Longitudinal antihypertensive prescription records (n = 42,367) were linked via the Kunshan Municipal Health Data Integration Platform, enabling detailed characterization of medication exposure patterns over time. Technical validation, including survival analysis, propensity score methods, and risk prediction modeling, was conducted to assess internal consistency and illustrate potential applications. This structured and de-identified dataset provides a quality-checked resource to support future research in osteoporosis, cardiovascular comorbidity, multimorbidity, and real-world comparative effectiveness studies.


  • Open Access

    Association between creatinine clearance and lumbar bone mineral density in Chinese patients with osteoporotic fractures: a retrospective cross-sectional study

    by Ming Su, Peng Zhou, Li-Long Feng, Hui-Qiang Shan, Min-Zhe Xu, Ya-Qin Gong, Jian Jin, Wen-Bin Hu, Ke Lu, Chong Li, et al.

    Background: Creatinine clearance (CCR) is an important marker of renal function. The association between CCR and lumbar bone mineral density (BMD) in patients with osteoporotic fractures (OPFs) remains unclear. With the increasing prevalence of OPFs in aging populations and the complications associated with renal impairment, understanding this relationship is essential for optimizing patient outcomes. Methods: A total of 1,313 patients with OPFs (aged ≥50 years) were retrospectively analyzed. Patient CCR, lumbar BMD, and relevant clinical data were collected. Lumbar BMD (g/cm 2 ) served as the outcome variable, while baseline CCR was the exposure variable. Multivariate analyses were performed with adjustments for multiple covariates. Results: In fully adjusted multivariate regression analysis, baseline CCR showed a significant positive correlation with lumbar BMD (β = 0.16; 95% CI: 0.13–0.18; P < 0.01). A threshold effect was identified in the CCR–BMD relationship, characterized by an inflection point at approximately 130 mL/min CCR. Below this threshold, higher CCR was associated with increased lumbar BMD. Above 130 mL/min, further increases in CCR were not associated with further BMD gains (β = –0.05, P = 0.18). Mean lumbar BMD values increased across CCR tertiles (0.69 ± 0.13, 0.73 ± 0.14, and 0.81 ± 0.15 g/cm 2 ; P < 0.01). Conclusion: CCR was positively associated with lumbar BMD among elderly patients with OPFs, showing a non-linear relationship characterized by a CCR threshold (~130 mL/min). These findings highlight the potential importance of renal function assessment in osteoporosis risk evaluation and fracture management.